NCT07102459Phase 2Completed

An Efficacy and Safety Study of LTG-001 Following Abdominoplasty

Study sponsor: Latigo Biotherapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-01-07Actual
Enrollment · participants343Actual
Source updated2026-04-29Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 360 participants (planned). After: 343 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2025. After: 7 Jan 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source